Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus
Wiadomości Lekarskie · 2024
DOI: 10.36740/wlek/191875 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Wiadomości Lekarskie, 2024. Verfasst von Zoriana Tylishchak und 6 weiteren Autor:innen. Beteiligte Einrichtung: IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE. Hauptthemen laut MEDLINE: Quercetin, Diabetes Mellitus, Type 2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To conduct a comparative analysis of the effectiveness of basic therapy and basic therapy with the inclusion of quercetin in patients with COVID-19 with concomitant type 2 diabetes. Material and methods There were examined 60 patients with COVID-19 with concomitant T2DM. Upon admission into the hospital and again after 10 days, serum levels of interleukin-6, C-reactive protein, procalcitonin, ferritin, endothelin-1 were determined, and capillaroscopy of the nail plate was performed. Patients of the group I (30) against the background of protocol therapy received 0.5 g of quercetin intravenously once a day for 10 days. Patients of the group II (30) received to basic therapy.
Results
After the treatment in patients of the group I general weakness decreased, body temperature normalized, improved saturation indicators, the level of acute-phase parameters (interleukin-6, CRP and ferritin) significantly decreased, a positive effect of quercetin on the level of D-dimer in blood serum was noted, indices of pericapillary edema and hemosiderin deposition significantly decreased, indices diameter of the arterial part of the capillary and capillary network density significantly increased.
Conclusions
The use of quercetin against the background of basic therapy in patients with COVID-19 and concomitant T2DM reliably reduces the level of acute-phase indices, has an important clinical significance for reducing endothelial dysfunction and for preventing thrombotic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.
Zitieren
APA
Tylishchak, Z., Pryshliak, O., Boichuk, O., Fedorov, S., Protsyk, A., Kobryn, T., & Miziuk, R. (2024). Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/191875
Vancouver
Tylishchak Z, Pryshliak O, Boichuk O, Fedorov S, Protsyk A, Kobryn T, et al. Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus. Wiadomości Lekarskie. 2024. doi:10.36740/wlek/191875
BibTeX
@article{Tylishchak2024,
author = {Tylishchak, Zoriana and Pryshliak, Oleksandra and Boichuk, Oleksandr and Fedorov, Sergiy and Protsyk, Andrii and Kobryn, Taras and Miziuk, Ruslan},
title = {Effectiveness of the quercetin use in patients with COVID-19 with concomitant type 2 diabetes mellitus},
journal = {Wiadomości Lekarskie},
year = {2024},
doi = {10.36740/wlek/191875}
}
EUVIMED